Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Lemtrada

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Alemtuzumab (Lemtrada) is a recombinant humanized IgG1 kappa monoclonal antibody to the surface cell glycoprotein, a CD52… Expand
2019
2019
Background There is a significant UK variation in the DMT sequencing strategies for high PML risk patients on Tysabri. In Greater… Expand
2017
2017
 
2016
2016
Stwardnienie rozsiane cześciej wystepuje u kobiet, a szczyt zachorowan przypada na wiek rozrodczy. Dlatego zagadnienie ciązy w… Expand
2015
2015
From 1 April 2015, Lemtrada (alemtuzumab) became available in Australia on the PBS for the treatment of relapsing forms of… Expand
Review
2015
Review
2015
  • 2015
  • Corpus ID: 35935741
NEW DRUG APPROVALS Blincyto for Rare Form of ALL The FDA has approved blinatumomab (Blincyto, Amgen) to treat patients with… Expand
2013
2013
Those who have already received a course of the drug need access until its re-release